Apotea AB (publ) (STO:APOTEA)
Sweden · Delayed Price · Currency is SEK 84.00
+2.70 (3.32%)
Sep 22, 2026, 5:29 PM CET
Apotea AB Market Cap
Apotea AB has a market cap or net worth of 8.74 billion as of September 22, 2026. Its market cap has decreased by -12.25% in one year.
Market Cap
8.74B
Enterprise Value
8.93B
Revenue
7.59B
Ranking
n/a
PE Ratio
35.59
Stock Price
84.00
ChartMarket Cap Chart
Since December 6, 2024, Apotea AB's market cap has increased from 8.63B to 8.74B, an increase of 1.29%. That is a compound annual growth rate of 0.72%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 22, 2026 | 8.74B | -8.91% |
| Dec 30, 2025 | 9.60B | 9.72% |
| Dec 30, 2024 | 8.75B | 1.35% |
| Dec 6, 2024 | 8.63B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Swedish Orphan Biovitrum AB | 154.37B |
| Getinge AB | 66.87B |
| Sectra AB | 54.06B |
| Medicover AB | 38.98B |
| Vitrolife AB | 12.57B |
| BioGaia AB | 11.09B |
| Dynavox Group AB | 8.09B |
| MedCap AB | 8.07B |